Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Aug 06, 2024

SELL
$195.21 - $310.53 $1,952 - $3,105
-10 Reduced 32.26%
21 $6,000
Q2 2022

Aug 06, 2024

BUY
$115.91 - $214.48 $579 - $1,072
5 Added 19.23%
31 $6,000
Q1 2022

Aug 06, 2024

BUY
$127.96 - $207.36 $3,326 - $5,391
26 New
26 $5,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.